TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Items tagged with Treatment

Charity demands Seoul allow TB medication shipment to N. Korea (post)

The nonprofit Eugene Bell Foundation on Thursday (December 22) called on the South Korean Ministry of Unification (MoU) to allow a shipment of multidrug-resistant tuberculosis (MDR-TB) medication to arrive in North Korea as it had promised in August.

Hospital against access to life-saving drug for TB patient as case reaches Delhi High Court (post)

Officials from the National Institute of Tuberculosis and Respiratory Diseases on Monday (January 9) told the Delhi High Court that providing bedaquiline, a life-saving drug, to an 18-year-old woman suffering from a drug-resistant form of TB would fail to treat her. They warned that it may cause the drug-resistant bacteria to spread in her body.

Reducing drug dosage, and hearing loss in TB patients without reducing efficacy (post)

Aminoglycosides, recommended by the World Health Organization to treat multidrug resistant tuberculosis, cause hearing loss and kidney damage in a dose dependent manner. Now, by reducing the dose in a carefully calculated fashion, Dutch clinician researchers have been able to greatly reduce the numbers of patients suffering hearing loss, without compromising effectiveness against tuberculosis. The research was published in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.

Delhi hospital agrees to give life-saving drug to TB patient after initial denial (post)

The National Institute of Tuberculosis and Respiratory Diseases on Wednesday (January 18) agreed to administer life-saving drug Bedaquiline to an 18-year-old woman from Patna who suffers from drug-resistant form of TB. “The drug has to be given in combination with other drugs, but doctors at the institute cannot give it to her without first conducting a drug-susceptibility test,” said Saket Sikri, the lawyer representing the institute at the Delhi High Court.

South Korea OKs Eugene Bell Foundation's plan to send TB medication to North Korea (post)

South Korea's Unification Ministry has approved an application by the Eugene Bell Foundation Korea to send medication for tuberculosis to North Korea, a government official said Wednesday (January 18).

India to roll out daily drug regimen for TB (post)

After a delay of nearly a year, the State is expected to roll out the daily drug regimen for treatment of tuberculosis (TB) under the Revised National Tuberculosis Control Programme (RNTCP) in February this year. All drug procurement logistics and trainings have been completed by the State.

India: HIV/TB coinfected people can get FDC drugs on daily basis in government hospitals (post)

HIV and TB affected persons can collect Fixed-Dose Combination (FDC) drugs to treat TB from government hospitals on a daily basis from Thursday (January 26).

Bedaquiline debate: Domicile requirement for TB patients to get live-saving drug may no longer apply (post)

An unreasonable domicile requirement that was responsible for denying the life-saving bedaquiline drug to many patients suffering from drug-resistant tuberculosis may no longer apply.

Pioneering new MSF-run clinical trial for drug-resistant TB treatment starts (post)

A pioneering new clinical trial aiming to find a radically improved course of treatment for drug-resistant tuberculosis (TB) began on 17th January 2017, when the first patient took the first pill in Uzbekistan.

Page 27 of 108 · Total posts: 0

←First 26 27 28 Last→